showed that ASTX600, an inhibitor of IAP1/2 and XIAP, proteins that modulate apoptosis and the tumor necrosis factor signaling pathway, significantly enhanced T-cell mediated tumor cell killing when combined with radiation and PD-1 inhibition in a mouse model of oral cavity carcinoma (42). This evidence concerns the gene PDCD1 and neoplasm.